Tomita Y
First Department of Surgery, Kurume University School of Medicine, Japan.
Nihon Geka Gakkai Zasshi. 1994 Jul;95(7):425-34.
Monoclonal antibody KYSM-1, whose immunoglobulin was IgM, was produced against human esophageal squamous cell carcinoma (KE-1) which has been maintained by serial subcutaneous transplantation in nude mice. In immunohistochemical reactions with various cancer tissues, KYSM-1 showed a strong reaction specific to squamous cell carcinomas of the esophagus, oral cavity and lung (92%, 95/103 and 100%, 3/3 and 100%, 7/7), with the lack of gastrointestinal adenocarcinomas and pulmonary nonsquamous cell carcinomas (small cell and large cell carcinomas). In contrast to this result, no reaction was recognized in several normal tissues, such as the lung, stomach, colon, liver, spleen, lymph node, pancreas, kidney, and mammary gland, however, a weak reaction was found in the basal layer of the esophageal mucosa. Antigenetic determinant of squamous cell carcinoma reactive with KYSM-1 was revealed to be protein moiety after enzyme treatment, and molecular weight of the antigen was about 60,000 analysed by Western blotting. These results suggest that KYSM-1 may be useful for not only immunoscintigraphy but also for the targeting chemotherapy.
单克隆抗体KYSM-1的免疫球蛋白为IgM,它是针对人食管鳞状细胞癌(KE-1)产生的,KE-1通过在裸鼠体内连续皮下移植得以保存。在与各种癌组织的免疫组化反应中,KYSM-1对食管、口腔和肺的鳞状细胞癌呈现出强烈的特异性反应(分别为92%,95/103;100%,3/3;100%,7/7),而对胃肠道腺癌和肺非鳞状细胞癌(小细胞癌和大细胞癌)无反应。与该结果相反,在肺、胃、结肠、肝、脾、淋巴结、胰腺、肾和乳腺等几种正常组织中未观察到反应,不过在食管黏膜基底层发现了微弱反应。经酶处理后发现,与KYSM-1反应的鳞状细胞癌抗原决定簇为蛋白质部分,通过蛋白质印迹法分析,该抗原的分子量约为60,000。这些结果表明,KYSM-1不仅可用于免疫闪烁显像,还可用于靶向化疗。